World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
30603
World Ranking
12652
National Ranking
38

Bon-Kwon Koo publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Bon-Kwon Koo sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 894 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Bon-Kwon Koo D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Bon-Kwon Koo sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Bon-Kwon Koo is affiliated with Seoul National University Hospital in South Korea. Their research primarily focuses on medicine, with a substantial emphasis on cardiology and cardiovascular medicine as well as surgery. Other notable fields of study include radiology, nuclear medicine and imaging, pulmonary and respiratory medicine, and biomedical engineering.

The scientist has a significant body of work in topics related to coronary interventions and diagnostics, cardiac imaging and diagnostics, and acute myocardial infarction research. Additional topics of interest include antiplatelet therapy and cardiovascular diseases, cerebrovascular and carotid artery diseases, peripheral artery disease management, and cardiac valve diseases and treatments.

Frequent publication venues for their work are:

  • Journal of the American College of Cardiology
  • European Heart Journal
  • JACC: Cardiovascular Interventions
  • Korean Circulation Journal
  • JACC Asia

Recent papers authored or co-authored by Bon-Kwon Koo include:

  • Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective, randomised, open-label, multicentre trial (2021) published in The Lancet
  • Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial (2020) published in The Lancet
  • Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial (2022) published in European Heart Journal
  • AI Evaluation of Stenosis on Coronary CTA, Comparison With Quantitative Coronary Angiography and Fractional Flow Reserve (2022) published in JACC. Cardiovascular Imaging
  • Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI (2022) published in New England Journal of Medicine

Bon-Kwon Koo collaborates regularly with several researchers. Frequent co-authors include:

  • Chang-Wook Nam
  • Doyeon Hwang
  • Joon-Hyung Doh
  • Eun-Seok Shin
  • Jeehoon Kang

Best Publications

  • Diagnosis of Ischemia-Causing Coronary Stenoses by Noninvasive Fractional Flow Reserve Computed From Coronary Computed Tomographic Angiograms : Results From the Prospective Multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve) Study

    Bonkwon Koo;Andrejs Erglis;Joon Hyung Doh;David V. Daniels

  • Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial

    Hyun-Jae Kang;Hyo-Soo Kim;Shu-Ying Zhang;Kyung-Woo Park

  • Diagnostic Accuracy of Fractional Flow Reserve From Anatomic CT Angiography

    James K. Min;Jonathon Leipsic;Michael J. Pencina;Daniel S. Berman

  • Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study

    Hyeon Cheol Gwon;Joo Yong Hahn;Kyung Woo Park;Young Bin Song

  • Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes.

    Nils P. Johnson;Gábor G. Tóth;Dejian Lai;Hongjian Zhu

  • Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials

    Seung-Kwon Myung;Woong Ju;Belong Cho;Seung-Won Oh

  • Physiologic Assessment of Jailed Side Branch Lesions Using Fractional Flow Reserve

    Bon-Kwon Koo;Hyun-Jai Kang;Tae-Jin Youn;In-Ho Chae

  • Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.

    Sang-Ho Jo;Tae-Jin Youn;Bon-Kwon Koo;Jin-Shik Park

  • Multicenter Core Laboratory Comparison of the Instantaneous Wave-Free Ratio and Resting Pd/Pa With Fractional Flow Reserve: The RESOLVE Study

    Allen Jeremias;Akiko Maehara;Philippe Généreux;Kaleab N. Asrress

  • Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.

    Hyun-Jae Kang;Hae-Young Lee;Sang-Hoon Na;Sung-A Chang

  • Identification of High-Risk Plaques Destined to Cause Acute Coronary Syndrome Using Coronary Computed Tomographic Angiography and Computational Fluid Dynamics.

    Joo Myung Lee;Gilwoo Choi;Bon Kwon Koo;Doyeon Hwang

  • Noninvasive fractional flow reserve derived from computed tomography angiography for coronary lesions of intermediate stenosis severity: results from the DeFACTO study.

    Ryo Nakazato;Hyung Bok Park;Daniel S. Berman;Heidi Gransar

  • Expert recommendations on the assessment of wall shear stress in human coronary arteries: existing methodologies, technical considerations, and clinical applications

    Frank Gijsen;Yuki Katagiri;Peter Barlis;Peter Barlis;Christos Bourantas;Christos Bourantas

  • Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel

    Jung Won Suh;Bonkwon Koo;Shu Ying Zhang;Kyung Woo Park

  • Atherosclerotic plaque characteristics by CT angiography identify coronary lesions that cause ischemia: a direct comparison to fractional flow reserve.

    Hyung Bok Park;Hyung Bok Park;Hyung Bok Park;Ran Heo;Ran Heo;Bríain Ó Hartaigh;Iksung Cho;Iksung Cho

  • Noninvasive Fractional Flow Reserve Derived From Coronary CT Angiography: Clinical Data and Scientific Principles.

    James K. Min;Charles A. Taylor;Stephan Achenbach;Bon Kwon Koo

  • Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve

    Bon-Kwon Koo;Kyung-Woo Park;Hyun-Jae Kang;Young-Seok Cho

  • Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial.

    Jung Won Suh;Jung Won Suh;Seung Pyo Lee;Kyung Woo Park;Hae Young Lee

  • Predictors and Outcomes of Side Branch Occlusion After Main Vessel Stenting in Coronary Bifurcation Lesions: Results From the COBIS II Registry (COronary BIfurcation Stenting)

    Joo Yong Hahn;Woo Jung Chun;Ji Hwan Kim;Young Bin Song

  • Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study.

    Sang-Ho Jo;Bon-Kwon Koo;Jin-Shik Park;Hyun-Jae Kang

Frequent Co-Authors

Hyo-Soo Kim
Hyo-Soo Kim Seoul National University Hospital
Byung Hee Oh
Byung Hee Oh Seoul National University Hospital
Javier Escaned
Javier Escaned Hospital Clínico San Carlos
James K. Min
James K. Min NewYork–Presbyterian Hospital
Peter J. Fitzgerald
Peter J. Fitzgerald Stanford University
William F. Fearon
William F. Fearon Stanford University
Takashi Akasaka
Takashi Akasaka Wakayama Medical University
Jonathon Leipsic
Jonathon Leipsic University of British Columbia
Daniel S. Berman
Daniel S. Berman Cedars-Sinai Medical Center
Bernard De Bruyne
Bernard De Bruyne Cardiovascular Center Aalst

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn’t always mean becoming a doctor. There are a variety of related degrees and career pathways you can pursue online to enter the healthcare field quickly and affordably.

Many students wonder about what is the fastest way to become an lpn. Fast-track LPN programs can help you start working as a licensed practical nurse in less time—ideal if you want to begin your career quickly.

For those interested in mental health, online psych np programs offer flexible options to specialize as a Psychiatric Mental Health Nurse Practitioner, often while continuing to work.

If management or leadership is your goal, you can find the cheapest online healthcare administration degree or pursue advanced roles through cheap mha programs. These degrees prepare you for roles overseeing healthcare facilities and services.

Whether you want to provide direct patient care or manage operations, these online pathways can help you achieve your goals efficiently and affordably.

Best Scientists Citing Bon-Kwon Koo

Trending Scientists

Recently Published Articles